+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID06125769

Liver Transplantation Study for Patients with Unresectable Perihilar Cholangiocarcinoma After Chemotherapy

Led by Azienda Sanitaria Ospedaliera · Updated on 2026-04-03

50

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating liver transplantation outcomes in patients with unresectable perihilar cholangiocarcinoma pCCA who have undergone standard chemotherapy. The study aims to assess overall survival and quality of life after transplantation, identify biological and clinical factors that predict better prognosis, and examine the role of preoperative PET-MRI imaging in relation to lymph node involvement. Patients will first receive six months of standard chemotherapy followed by PET-MRI to rule out disease spread outside the liver. Those with stable disease will be listed for liver transplantation, which includes exploratory surgery and lymph node evaluation before the procedure. Transplantation follows institutional protocols and may involve cadaveric or living donor livers, whole or partial. Participants will undergo routine imaging, clinical evaluations, and histological examinations of lymph nodes during surgery. Researchers will monitor survival up to five years, progression-free survival, quality of life using questionnaires, cancer-related mortality, and postoperative complications. The study includes long-term follow-up to compare outcomes with chemotherapy alone and to validate imaging and biological markers.

CONDITIONS

Brief Title

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

Research Team

E

Enrico Gringeri, Prof.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here